Pharma & Healthcare

Global Sargramostim Market Research Report 2026

This report delivers a comprehensive overview of the global Sargramostim market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sargramostim. The Sargramostim market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sargramostim market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sargramostim manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Partner Therapeutics
Nobelpharma
Segment by Type
Injection
Inhalation
by Application
Acute Radiation Syndrome
Proteinosis Autoimmune Pulmonary Alveolar
Cancer
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sargramostim manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sargramostim sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Sargramostim Market Overview
1.1 Product Definition
1.2 Sargramostim by Type
1.2.1 Global Sargramostim Market Value by Type: 2025 vs 2032
1.2.2 Injection
1.2.3 Inhalation
1.3 Sargramostim by Application
1.3.1 Global Sargramostim Market Value by Application: 2025 vs 2032
1.3.2 Acute Radiation Syndrome
1.3.3 Proteinosis Autoimmune Pulmonary Alveolar
1.3.4 Cancer
1.3.5 Other
1.4 Global Sargramostim Market Size Estimates and Forecasts
1.4.1 Global Sargramostim Revenue 2021–2032
1.4.2 Global Sargramostim Sales 2021–2032
1.4.3 Global Sargramostim Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Sargramostim Market Competition by Manufacturers
2.1 Global Sargramostim Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sargramostim Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sargramostim Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sargramostim, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sargramostim, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sargramostim, Product Types and Applications
2.7 Global Key Manufacturers of Sargramostim, Date of Entry into the Industry
2.8 Global Sargramostim Market Competitive Situation and Trends
2.8.1 Global Sargramostim Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sargramostim Players Market Share by Revenue
2.8.3 Global Sargramostim Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sargramostim Market Scenario by Region
3.1 Global Sargramostim Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sargramostim Sales by Region: 2021–2032
3.2.1 Global Sargramostim Sales by Region: 2021–2026
3.2.2 Global Sargramostim Sales by Region: 2027–2032
3.3 Global Sargramostim Revenue by Region: 2021–2032
3.3.1 Global Sargramostim Revenue by Region: 2021–2026
3.3.2 Global Sargramostim Revenue by Region: 2027–2032
3.4 North America Sargramostim Market Facts & Figures by Country
3.4.1 North America Sargramostim Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sargramostim Sales by Country (2021–2032)
3.4.3 North America Sargramostim Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sargramostim Market Facts & Figures by Country
3.5.1 Europe Sargramostim Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sargramostim Sales by Country (2021–2032)
3.5.3 Europe Sargramostim Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sargramostim Market Facts & Figures by Region
3.6.1 Asia Pacific Sargramostim Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sargramostim Sales by Region (2021–2032)
3.6.3 Asia Pacific Sargramostim Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sargramostim Market Facts & Figures by Country
3.7.1 Latin America Sargramostim Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sargramostim Sales by Country (2021–2032)
3.7.3 Latin America Sargramostim Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sargramostim Market Facts & Figures by Country
3.8.1 Middle East and Africa Sargramostim Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sargramostim Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sargramostim Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sargramostim Sales by Type (2021–2032)
4.1.1 Global Sargramostim Sales by Type (2021–2026)
4.1.2 Global Sargramostim Sales by Type (2027–2032)
4.1.3 Global Sargramostim Sales Market Share by Type (2021–2032)
4.2 Global Sargramostim Revenue by Type (2021–2032)
4.2.1 Global Sargramostim Revenue by Type (2021–2026)
4.2.2 Global Sargramostim Revenue by Type (2027–2032)
4.2.3 Global Sargramostim Revenue Market Share by Type (2021–2032)
4.3 Global Sargramostim Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sargramostim Sales by Application (2021–2032)
5.1.1 Global Sargramostim Sales by Application (2021–2026)
5.1.2 Global Sargramostim Sales by Application (2027–2032)
5.1.3 Global Sargramostim Sales Market Share by Application (2021–2032)
5.2 Global Sargramostim Revenue by Application (2021–2032)
5.2.1 Global Sargramostim Revenue by Application (2021–2026)
5.2.2 Global Sargramostim Revenue by Application (2027–2032)
5.2.3 Global Sargramostim Revenue Market Share by Application (2021–2032)
5.3 Global Sargramostim Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Partner Therapeutics
6.1.1 Partner Therapeutics Company Information
6.1.2 Partner Therapeutics Description and Business Overview
6.1.3 Partner Therapeutics Sargramostim Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Partner Therapeutics Sargramostim Product Portfolio
6.1.5 Partner Therapeutics Recent Developments/Updates
6.2 Nobelpharma
6.2.1 Nobelpharma Company Information
6.2.2 Nobelpharma Description and Business Overview
6.2.3 Nobelpharma Sargramostim Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nobelpharma Sargramostim Product Portfolio
6.2.5 Nobelpharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sargramostim Industry Chain Analysis
7.2 Sargramostim Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sargramostim Production Mode & Process Analysis
7.4 Sargramostim Sales and Marketing
7.4.1 Sargramostim Sales Channels
7.4.2 Sargramostim Distributors
7.5 Sargramostim Customer Analysis
8 Sargramostim Market Dynamics
8.1 Sargramostim Industry Trends
8.2 Sargramostim Market Drivers
8.3 Sargramostim Market Challenges
8.4 Sargramostim Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sargramostim Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Sargramostim Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Sargramostim Market Competitive Situation by Manufacturers in 2025
Table 4. Global Sargramostim Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Sargramostim Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Sargramostim Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Sargramostim Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Sargramostim Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Sargramostim, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Sargramostim, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Sargramostim, Product Types and Applications
Table 12. Global Key Manufacturers of Sargramostim, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sargramostim Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sargramostim Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sargramostim Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Sargramostim Sales by Region (K Units), 2021–2026
Table 18. Global Sargramostim Sales Market Share by Region (2021–2026)
Table 19. Global Sargramostim Sales by Region (K Units), 2027–2032
Table 20. Global Sargramostim Sales Market Share by Region (2027–2032)
Table 21. Global Sargramostim Revenue by Region (US$ Million), 2021–2026
Table 22. Global Sargramostim Revenue Market Share by Region (2021–2026)
Table 23. Global Sargramostim Revenue by Region (US$ Million), 2027–2032
Table 24. Global Sargramostim Revenue Market Share by Region (2027–2032)
Table 25. North America Sargramostim Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Sargramostim Sales by Country (K Units), 2021–2026
Table 27. North America Sargramostim Sales by Country (K Units), 2027–2032
Table 28. North America Sargramostim Revenue by Country (US$ Million), 2021–2026
Table 29. North America Sargramostim Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Sargramostim Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Sargramostim Sales by Country (K Units), 2021–2026
Table 32. Europe Sargramostim Sales by Country (K Units), 2027–2032
Table 33. Europe Sargramostim Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Sargramostim Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Sargramostim Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Sargramostim Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Sargramostim Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Sargramostim Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Sargramostim Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Sargramostim Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Sargramostim Sales by Country (K Units), 2021–2026
Table 42. Latin America Sargramostim Sales by Country (K Units), 2027–2032
Table 43. Latin America Sargramostim Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Sargramostim Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Sargramostim Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Sargramostim Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Sargramostim Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Sargramostim Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Sargramostim Revenue by Country (US$ Million), 2027–2032
Table 50. Global Sargramostim Sales (K Units) by Type (2021–2026)
Table 51. Global Sargramostim Sales (K Units) by Type (2027–2032)
Table 52. Global Sargramostim Sales Market Share by Type (2021–2026)
Table 53. Global Sargramostim Sales Market Share by Type (2027–2032)
Table 54. Global Sargramostim Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Sargramostim Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Sargramostim Revenue Market Share by Type (2021–2026)
Table 57. Global Sargramostim Revenue Market Share by Type (2027–2032)
Table 58. Global Sargramostim Price (US$/Unit) by Type (2021–2026)
Table 59. Global Sargramostim Price (US$/Unit) by Type (2027–2032)
Table 60. Global Sargramostim Sales (K Units) by Application (2021–2026)
Table 61. Global Sargramostim Sales (K Units) by Application (2027–2032)
Table 62. Global Sargramostim Sales Market Share by Application (2021–2026)
Table 63. Global Sargramostim Sales Market Share by Application (2027–2032)
Table 64. Global Sargramostim Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Sargramostim Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Sargramostim Revenue Market Share by Application (2021–2026)
Table 67. Global Sargramostim Revenue Market Share by Application (2027–2032)
Table 68. Global Sargramostim Price (US$/Unit) by Application (2021–2026)
Table 69. Global Sargramostim Price (US$/Unit) by Application (2027–2032)
Table 70. Partner Therapeutics Company Information
Table 71. Partner Therapeutics Description and Business Overview
Table 72. Partner Therapeutics Sargramostim Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Partner Therapeutics Sargramostim Product
Table 74. Partner Therapeutics Recent Developments/Updates
Table 75. Nobelpharma Company Information
Table 76. Nobelpharma Description and Business Overview
Table 77. Nobelpharma Sargramostim Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Nobelpharma Sargramostim Product
Table 79. Nobelpharma Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Sargramostim Distributors List
Table 83. Sargramostim Customers List
Table 84. Sargramostim Market Trends
Table 85. Sargramostim Market Drivers
Table 86. Sargramostim Market Challenges
Table 87. Sargramostim Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Product Picture of Sargramostim
Figure 2. Global Sargramostim Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Sargramostim Market Share by Type: 2025 & 2032
Figure 4. Injection Product Picture
Figure 5. Inhalation Product Picture
Figure 6. Global Sargramostim Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Sargramostim Market Share by Application: 2025 & 2032
Figure 8. Acute Radiation Syndrome
Figure 9. Proteinosis Autoimmune Pulmonary Alveolar
Figure 10. Cancer
Figure 11. Other
Figure 12. Global Sargramostim Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Sargramostim Market Size (US$ Million), 2021–2032
Figure 14. Global Sargramostim Sales (K Units), 2021–2032
Figure 15. Global Sargramostim Average Price (US$/Unit), 2021–2032
Figure 16. Sargramostim Report Years Considered
Figure 17. Sargramostim Sales Share by Manufacturers in 2025
Figure 18. Global Sargramostim Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Sargramostim Players: Market Share by Revenue in Sargramostim in 2025
Figure 20. Sargramostim Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Sargramostim Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Sargramostim Sales Market Share by Country (2021–2032)
Figure 23. North America Sargramostim Revenue Market Share by Country (2021–2032)
Figure 24. United States Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Sargramostim Sales Market Share by Country (2021–2032)
Figure 27. Europe Sargramostim Revenue Market Share by Country (2021–2032)
Figure 28. Germany Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Sargramostim Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Sargramostim Revenue Market Share by Region (2021–2032)
Figure 35. China Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Sargramostim Sales Market Share by Country (2021–2032)
Figure 43. Latin America Sargramostim Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Sargramostim Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Sargramostim Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Sargramostim Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Sargramostim by Type (2021–2032)
Figure 54. Global Revenue Market Share of Sargramostim by Type (2021–2032)
Figure 55. Global Sargramostim Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Sargramostim by Application (2021–2032)
Figure 57. Global Revenue Market Share of Sargramostim by Application (2021–2032)
Figure 58. Global Sargramostim Price (US$/Unit) by Application (2021–2032)
Figure 59. Sargramostim Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies